10 December 2021
We're delighted to confirm continued funding until 2026 for our Rheumatoid Arthritis Register (BSRBR-RA) and Psoriatic Arthritis Register (BSR-PsA).
It's more important than ever for centres across the UK to continue to engage with these studies if they can. Data collected from these studies generates vital long-term evidence on patient safety, treatment efficacy and COVID-19 data, helping highlight the effects the pandemic's having on our rheumatology community.
Prof Kimme Hyrich, Principal Investigator on the BSRBR-RA Register, says: “I'm absolutely delighted we've secured a further five years of funding. This represents an exciting yet challenging time for rheumatology, particular with the introduction of newer therapies such as JAK inhibitors, so it's important we continue to collect data from patients receiving these newer treatments to address our clinical queries.
"We've established further academic collaborations with King’s College London, bringing in expertise through integration of the BSRBR-RA and BSR's ePROMs platform and have strengthened our links with NRAS to ensure research is always patient-focused.
"BSRBR-RA is an incredible resource created by and for the rheumatology community. I encourage everyone with research questions and clinical queries to contact the study team to discuss ways to fully realise the potential of this world-leading data source.”
Gareth Jones, Chief Investigator on the BSR-PsA Register adds: “The ability to collect longer-term patient follow-up data is of enormous benefit, allowing us to examine rarer outcome events. Increasing the duration of recruitment on the study provides a larger patient cohort; particularly good news given the understandable impact the COVID-19 pandemic has had on study recruitment and participation in current research".
Ali Rivett, BSR Chief Executive adds: “These flagship projects are incredibly valuable to BSR and the wider community. Both universities offered compelling and innovative proposals for the development of these studies, which strengthen our collaboration with centres and continue to highlight the value and impact of these datasets.”